KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 120 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,533,000 | +12.1% | 406,800 | -11.6% | 0.10% | +33.3% |
| Q4 2017 | $1,367,000 | +270.5% | 460,200 | +625.9% | 0.07% | +24.1% |
| Q2 2016 | $369,000 | +0.8% | 63,400 | 0.0% | 0.06% | -29.3% |
| Q1 2016 | $366,000 | -89.3% | 63,400 | -89.7% | 0.08% | -80.6% |
| Q4 2015 | $3,413,000 | +5.3% | 615,800 | +21.3% | 0.42% | -49.8% |
| Q3 2015 | $3,241,000 | +25.8% | 507,600 | +39.7% | 0.84% | +174.3% |
| Q2 2015 | $2,577,000 | +3081.5% | 363,400 | +3534.0% | 0.31% | +2970.0% |
| Q1 2015 | $81,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |